97101 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
Sub-classes:Anti-Inflammatory Polypeptides
#2VISCOSITY-REDUCING EXCIPIENT COMPOSITION AND LOW-VISCOSITY HIGHLY CONCENTRATED PROTEIN FORMULATION CONTAINING SAME
#3TREATMENT OF CIDP
#4PROCESS FOR PREPARATION OF SECRETORY IgA AND SECRETORY IgM AND USE THEREOF FOR TREATING NECROTIZING ENTEROCOLITIS
#5Early Detection Of Hepatocellular Carcinoma
#6SYSTEMS FOR EXTRACTING PROTEINS FROM A BLOOD-BASED MATERIAL
#7METHODS FOR THE PRODUCTION OF THERAPEUTIC, DIAGNOSTIC, OR RESEARCH ANTIBODIES
#8Epitope Modification
#9SERUM HALF-LIFE EXTENDED PD-L1 BINDING POLYPEPTIDES
#10IgG EPITOPE AND APPLICATIONS THEREOF AS A DRUG TARGET
#11MAMMALIAN ARTIFICIAL CHROMOSOME VECTOR HAVING HUMAN IMMUNOGLOBULIN HEAVY CHAIN LOCUS COMPRISING MODIFIED D-REGION, AND CELL OR NON-HUMAN ANIMAL RETAINING THE VECTOR
#12AUTOIMMUNE ANTIBODIES FOR USE IN INHIBITING CANCER CELL GROWTH
#13COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES
#14TREATMENT OF INTESTINAL LUMEN IMMUNOGLOBULIN DEFICIENCY WITH SEMISYNTHETIC POLYCLONAL HUMAN SECRETORY IMMUNOGLOBIN A
#15PRINTED COMPOSITION FOR BIOMEDICAL USES
#16Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#17COMPOSITIONS AND METHODS FOR INJECTING PARTICLE SUSPENSIONS
#18ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION
#19Injectable Polymeric Biopharmaceutical Formulations
#20METHODS FOR DELIVERING ANTIBODIES TO THE FETAL CIRCULATION
#21TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
#22THE USE OF INTRAVENOUS IMMUNOGLOBULIN IN THE PREPARATION OF A DRUG FOR THE TREATMENT OF CUTIS VERTICIS GYRATA DISEASE
#23METHOD OF PREPARING ANTIBODY CARRYING A UNIVERSAL SITE-DIRECTED COUPLING INTERFACE BASED ON GENETICALLY MODIFIED VERTEBRATE
#24Sialylated Glycoproteins
#25COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY
#26METHODS FOR QUANTITATING INDIVIDUAL ANTIBODIES FROM A MIXTURE
#27CELL CULTURE PROCESSES
#28METHODS OF IMPROVING PROTEIN EXPRESSION
#29OLIGONUCLEOTIDES TARGETING XBP1
#30Anti-Inflammatory Polypeptides
#31MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS
#32METHOD FOR THE TREATMENT OF VIRUS INFECTION WITH IVIG AND CONVALESCENT PLASMA
#33HYPER-SIALYLATED IMMUNOGLOBULIN
#34Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#35Methods for quantitating individual antibodies from a mixture
#36Early Detection Of Hepatocellular Carcinoma
#37ENRICHMENT OF ANTIGEN-SPECIFIC ANTIBODIES FOR ANALYTIC AND THERAPEUTIC USE
#38Immunoglobulin Preparation and Storage System for an Immunoglobulin Preparation
#39Human interleukin-4 receptor alpha antibodies
#40Compositions and methods for the treatment of immunodeficiency
#41Methods for Extracting Proteins from a Blood-Based Material
#42A COMBINATION OF PLASMA IMMUNOGLOBULIN AND ANTIGEN-SPECIFIC IMMUNOGLOBULIN FOR THE MODIFICATION OF THE IMMUNE SYSTEM AND THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES
#43METHODS OF PERMITTING A SUBJECT TO RECEIVE MULTIPLE DOSES OF RECOMBINANT ADENO-ASSOCIATED VIRUS
#44Methods of treating Kawasaki disease
#45NON-HUMAN ANIMALS HAVING A LIMITED LAMBDA LIGHT CHAIN REPERTOIRE EXPRESSED FROM THE KAPPA LOCUS AND USES THEREOF
#46HUMANIZED TRANSGENIC MOUSE MODEL
#47Animal models and therapeutic molecules
#48Methods for the treatment of neurodegeneration
#49INNOVATIVE PRODUCTION TECHNIQUE FOR ANTIBODY-ENZYME
#50VECTORS AND EXPRESSION SYSTEMS FOR PRODUCING RECOMBINANT PROTEINS
#51IVIG TREATMENTS FOR SUDDEN SONSORINEURAL HEARING LOSS
#52Monoclonal Antibodies to ELTD1 and Uses Thereof
#53Mut- methylotrophic yeast
#54Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#55Autoimmune antibodies for use in inhibiting cancer cell growth
#56antiserum without cross-reactivity and method for producing the same
#57METHOD FOR LARGE SCALE PRODUCTION OF ANTIBODIES USING A CELL-FREE PROTEIN SYNTHESIS SYSTEM
#586-acetylmorphine analogs, and methods for their synthesis and use
#59EXPRESSION VECTORS FOR EUKARYOTIC EXPRESSION SYSTEMS
#60METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING ACUTE EXACERBATIONS WITH POLYCLONAL IMMUNOGLOBULIN
#61Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#62IVIG COMPOSITION AND METHOD OF TREATMENT OF ANTIBODY DEFICIENT PATIENTS
#63Methods for the production of therapeutic, diagnostic, or research antibodies
#64IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES
#65Methods for quantitating individual antibodies from a mixture
#66Methods for extracting proteins from a blood-based material
#67ANTI-XYLAN SULFATE POLYCLONAL ANTISERUM AND USE THEREOF IN ELISA METHODS
#68TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G
#69TREATMENT OF CIDP
#70ZIKA NEUTRALIZING ANTIBODY COMPOSITIONS AND METHODS OF USING THE SAME
#71Anti-inflammatory polypeptides
#72Compositions and methods for the treatment of immunodeficiency
#73ANTI-GALECTIN ANTIBODY BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT AND ANTI-ANGIOGENESIS RESPONSES
#74Anti-inflammatory polypeptides
#75Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
#76Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#77Methods for quantitating individual antibodies from a mixture
#78Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy
#79ANTIBODY FOR DETECTING EARLY DAMAGE TO BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND USE THEREOF
#80Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#81Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies
#82INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME
#83Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
#84IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES
#85Method of treating mammals displaying severe neurological symptoms of advanced canine distemper virus infection using NDV-induced serum
#86Purification process for removal of tyrosine sulfation antibody variants; purified compositions
#87Treatment of intestinal dysbiosis with immunoglobin
#88IMMUNOGLOBULIN PRODUCTS FOR USE IN THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
#89Methods for the treatment of neurodegeneration
#90Immunoglobulin preparation and storage system for an immunoglobulin preparation
#91COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES
#92Serological assay for the detection of zika virus-specific antibodies utilizing overlapping peptides comprising an NS2B epitope
#93Methods for affecting infections
#94Methods of treating Kawasaki Disease
#95Animal models and therapeutic molecules
#96Human antibody-producing non-human animal and method for preparing human antibodies using same
#97Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#98Methods for quantitating individual antibodies from a mixture
#99TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G
#100Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#101Early detection of hepatocellular carcinoma
#102Methods and systems for autoinduction of protein expression
#103Methods for the production of therapeutic, diagnostic, or research antibodies
#104TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
#105Methods for extracting proteins from a blood-based material
#106Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#107Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#1086-ACETYLMORPHINE ANALOGS, AND METHODS FOR THEIR SYNTHESIS AND USE
#109Sialylated glycoproteins
#110Circulating antibodies against MAA adducts as biomarker for coronary artery disease
#111CELL CULTURE METHODS AND SYSTEMS
#112IgG stimulated remyelination of peripheral nerves
#113Antibody for immunoassay and method for preparing same
#114Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#115Compositions and methods for the treatment of immunodeficiency
#116Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof
#117COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES
#118AUTOIMMUNE ANTIBODIES FOR USE IN INHIBITING CANCER CELL GROWTH
#119Compositions and methods for the treatment of immunodeficiency
#120Anti-inflammatory polypeptides
#121Animal models and therapeutic molecules
#122MT-45 IMMUNODETECTION
#123Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responses
#124Methods for Treating HIV-Associated Enteropathy Symptoms With Immunoglobulin/Protein Isolate
#125Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#1266-acetylmorphine analogs, and methods for their synthesis and use
#127Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity
#128Method for the preparation of immunoglobulins
#129Mouse λ light chain locus
#130Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
#131Immunoglobulin preparation and storage system for an immunoglobulin preparation
#132Therapeutic peptides
#133Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy
#134Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
#135METHOD OF ADMINISTRATING IgC COMPOSITIONS TO PROVIDE SUSTAINED LEVELS OF AMINO ACIDS
#136Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT)
#137Canine health product containing antibodies against canine parvovirus type 2
#138Method for increasing milk production by ruminants
#139Compositions and methods for the treatment of immunodeficiency
#140Compositions and methods for the treatment of immunodeficiency
#141CONCENTRATED HUMAN IMMUNOGLOBULIN COMPOSITION
#1426-acetylmorphine analogs, and methods for their synthesis and use
#143Methods of administering IgG1 antibodies and methods of suppressing angiogenesis
#144Diagnosis of a neurological disease
#145Amphiphilic derivatives of triazamacrocyclic compounds, products and compositions including same, and synthesis methods and uses thereof
#146HUMAN POLYCLONAL ANTIBODIES FROM GENETICALLY ENGINEERED ANIMALS
#147IGM THERAPY IN PREVENTION OF ONSET, PROGRESSION, AND RECURRENCE OF AUTOIMMUNE TYPE 1 DIABETES
#148IgG stimulated remyelination of peripheral nerves
#149Method of generating antibodies
#150Polyclonal bispecific antibody compositions and method of use
#151Treatment of mucositis with immunoglobulin
#152Production of heavy chain only antibodies in transgenic mammals
#153Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
#154Subcutaneous administration of anti-hepatitis B antibodies
#155Animal models and therapeutic molecules
#156Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
#157Combination therapy using immunoglobulin and C1-Inhibitor
#158Method for preparing a concentrate of polyvalent immunoglobulin
#159Therapeutic peptides
#160Antivenom
#161HUMANIZED TRANSGENIC MOUSE MODEL
#162TREATMENT OF MS WITH GOAT SERUM
#163Concentrated human immunoglobulin composition
#164Immunoglobulin preparations having increased stability
#165Mouse λ light chain locus
#166Immunoglobulin preparation and storage system for an immunoglobulin preparation
#167Rapid, Sensitive and Quantitative Methods for Tissue and Cell-Based Proteomics Via Consecutive Additional Quantifiable Extenders
#168INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS
#169Use of goat serum for veterinary treatment
#170Polyclonal bispecific antibody compositions and method of use
#171USE OF CYTOKINE LEVELS IN INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF ALZHEIMER'S DISEASE
#172METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE-CHALLENGED ANIMALS
#173METHODS OF USING IMMUNOGLOBULIN AGGREGATES
#174Treatment of Fibrosis related disorders
#175IMMUNOGLOBULIN G COMPOSITION
#176Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT)
#177Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
#178Use a goat serum for veterinary treatment
#179POLYPEPTIDES WITH ENHANCED ANTI-INFLAMMATORY AND DECREASED CYTOTOXIC PROPERTIES AND RELATING METHODS
#180Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
#181Method for quantification of antigen-specific canine IgE
#182Mouse λ light chain locus
#183Treatment of MS with goat serum
#184Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
#185COMPLEXES OF GRP94 WITH HUMAN IMMUNOGLOBULIN G
#186Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
#187Treatment methods for fibrosis related disorders
#188METHODS AND COMPOSITIONS OF TREATMENT FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS
#189Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
#190Therapeutic use of IgG as a neuroprotective agent
#191Subcutaneous administration of anti-hepatitis B antibodies
#192PRODUCTS FOR PROPHYLAXIS AND/OR TREATMENT OF VIRAL DISEASES AND METHODS OF MAKING AND USING SAME
#193METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#194Method of Treating Cancer with Immunomodulatory Compounds and IgG
#195Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
#196INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS
#197COMPOSITIONS AND METHODS FOR TREATING HERPES SIMPLEX VIRUS INFECTIONS AND RELATED DISEASES
#198Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
#199PREVENTION OF BRAIN INFLAMMATION AS A RESULT OF INDUCED AUTOIMMUNE RESPONSE
#200METHODS AND COMPOSITIONS FOR TREATING HERPES INFECTIONS
#201Use of goat serum for veterinary treatment
#202Transfer Factor Compositions and Methods
#203Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
#204Human Polyclonal Antibodies from Genetically Engineered Animals
#205Immunoglobin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
#206Treatment of Diseases
#207Concentrate of Chikungunya-Specific Immunoglobulins as a Medicinal Product
#208METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE DYSFUNCTION DISORDERS
#209POLYPEPTIDES WITH ENHANCED ANTI-INFLAMMATORY AND DECREASED CYTOTOXIC PROPERTIES AND RELATING METHODS
#210METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS
#211Naturally occuring IgM antibodies that bind lymphocytes
#212Water-soluble globulin concentrate for improving growth in animals
#213Administration of gamma globulins to treat metastatic melanoma
#214Use of Goat Serum for Veterinary Treatment
#215Protein purification
#216Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
#217Immunoglobulin preparations having increased stability
#218Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
#219Stable antibody formulation
#220Method for the treatment or prophylaxis of tuberculosis
#221Methods and compositions for treating herpes infections
#222Peptides for inhibiting retroviruses
#223Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
#224Crystals of the Fc region of immunoglobulin epsilon heavy chain protein
#225Methods and compositions for modulating the immune system of animals
#226Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals
#227Three-dimensional model of a Fc region of an IgE antibody and uses thereof
#228Immunoglobulin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
#2297s immunoglobulin for treatment of choroidal neovascularisation
#230Mouse λ light chain locus
#231Methods and compositions for treating herpes infections
#232Method, systems and kits for immuno-detection of epitopes expressed on molecules
#233Method and device for intrathecal administering of immunoglobulin